TrialJAMA neurology2018

Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.

Virginia L Stauffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.